Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A0LE
|
|||
| Former ID |
DNC013305
|
|||
| Drug Name |
3-(2-methylbenzo[d]thiazol-5-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL244585; 3-(2-methylbenzo[d]thiazol-5-yl)benzonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H10N2S
|
|||
| Canonical SMILES |
CC1=NC2=C(S1)C=CC(=C2)C3=CC=CC(=C3)C#N
|
|||
| InChI |
1S/C15H10N2S/c1-10-17-14-8-13(5-6-15(14)18-10)12-4-2-3-11(7-12)9-16/h2-8H,1H3
|
|||
| InChIKey |
QCTQEXSACACMOJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2987-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.